Morphometry and quantitative modeling: MIAC efforts focus on developing and combining morphometric markers, which allow for (automated) digital image processing in the context of large multi-center studies.
Your study. Our expertise.
Customized data analysis for your study, with our expertise and commitment for quality.
MIAC Academy 2023
In 2023, we will again organize our well-established MIAC Academy. Contact us for more information on this highly specialized and interactive training course for clinicians in neurology and radiology.
Since 1995, MIAC has been committed to deliver fully-personalized data analysis for pharmaceutical and academic research.
Advanced image analysis technologies and high impact scientific outcomes for your international trial with our expertise and commitment for personalized customer service.
Tailor-made data analysis pipelines in Swiss quality standards ensure custom metrics and transparent gapless data safety for your imaging study.
The Medical Image Analysis Center (MIAC) is a clinical research organisation supporting international trials with advanced image acquisition and analysis technologies. As an academic corporation that was founded at the Basel University Hospital in 1995, MIAC today is tightly embedded in a national and international institutions and research network, driving the translation of novel imaging and post-processing modalities from development to application in clinical trials.
A highly specialized team of board-certified neuro-/radiologists, physicists, biomedical engineers, IT specialists, technicians and clinicians deliver tailor-made image data analysis services and international trial support to the leaders of the pharmaceutical industry.
All MIAC services follow the high standards of Swiss quality and comply with the requirements of FDA – 21 CFR Part 11 & ICH – Good Clinical Practices.
MIAC provides an extensive suite of services to successfully plan, organize, and lead your international trial.
MIAC is your certified partner and reference center for phase II, III and IV trials and has been analyzing international key studies for more than two decades, establishing a well-cited track record with scientific and commercial partners.
Output & Performance
Our in-house specialists of board-certified neuro-/radiologists, experienced MR physicists, MR technicians and image analysis experts provide an extensive support in planning and setting-up your study, identifying the most relevant outcome biomarker(s) and designing state of the art analysis pipelines that include all necessary validation and quality assurance steps.
At MIAC, we benefit from over 25 years experience in designing and conducting imaging protocols in scientific and clinical trials, from small pilot projects to large world-wide phase III trials on all continents. We provide 24/7 support for every aspect of your study, from site selection, technical assistance to quality assurance, 365 days a year. Our long-term expertise and know-how in data management allows us to assist you to safely collect, manage and store your data in a secured environment easily accessible via our study specific web portals.
We offer standard and custom analyses for every kind of medical image data (i.e. MRI, CT, PET, OCT) including advanced / future modalities (i.e. ultralow and ultrahigh field MRI, MR fingerprinting, MR elastography). Our extensive library of studies, validated workflows and data management pipelines ensure quantitative, structural and functional image analyses in highest quality and reliability. In addition to routine quantification algorithms, we aim to provide tailored in-house solutions for every imaging aspect of your specific study.
Output & Performance
Our webportal enables you to monitor your study progress in real-time, providing you with a comprehensive overview and full control of the study process. Our experienced staff of scientists, neuro-/radiologists, MR physicists and image analysis experts gladly assist you in achieving an optimal trial outcome. We personally support each participating site world-wide during the trial, contribute to scientific and statistical analyses, and provide personal guidance for the interpretation and summary of study results aiming at high impact publications.
MIAC covers a wide range of research activities in the field of medical imaging.
Our in-house research unit is embedded in a national and international network driving the translation of novel imaging and post-processing modalities from development to applications in clinical trials. MIAC closely collaborates with the qbig (Quantitative Biomedical Imaging Group), the AMT (Adaptable MRI Technology) lab, the CIAN (Center for medical Image Analysis and Navigation), and the ThINk (Translational Imaging in Neurology) group at the Department of Biomedical Engineering at University Basel.
Image-based biomarkers pipelines
Imaging phenotypes: Our work aims to detail the morphology of various brain lesions by using advanced neuroimaging techniques to establish new diagnostic and prognostic imaging biomarkers.
Data standardization and homogenization pipelines
Data preparation and processing paradigms: MIAC is developing systems and platforms that support building and using tailored image processing tasks in a standardized modular framework.
Phantom design: MIAC efforts focus on building a modular framework for the construction of 3D-printed brain phantoms, which realistically mimic both anatomy and imaging properties of human brain regions.
Advanced tissue characerization
Arterial spin labeling perfusion and permeability: Our current research focuses on assessing changes in brain perfusion or permeability using an optimized ASL protocol.
MR elastography: MIAC efforts currently focus on defining, optimizing and validating MR elastography protocols to finally evaluate its clinical performance in assessing disease progression or treatment response.
Quantitative contrast mechanisms and ultrahigh field imaging: We integrate advanced neuroimaging techniques such as ultrahigh field MRI at 7 Tesla, quantitative contrast mechanisms and artificial intelligence powered automated segmentation methods to better detect and understand neurodegeneration.
Functional imaging: The analyses of changes in brain activity allow us to study the neuronal plasticity induced by clinical interventions in both healthy subjects and clinical populations.
Our expertise for your profession.
The MIAC Academy is an integral part of the portfolio of MIAC AG, adding the educational section to the scientific and business research areas. Established in 2017, the MIAC Academy offers a unique educational program and comprehensive workshops for clinicians in neurology, neuroimmunology and (neuro-) radiology. MIAC's global network of experts presents state of the art topics across the MS spectrum, NMOSD, and Alzheimer's Disease in an interactively designed program. For further information contact our MIAC Academy Events Team.
Participant's feedback of our latest MIAC Academy:
"I can only express my gratitude for such a good event! Well done, I am looking forward to the next!"
"Really interesting topics and very good organisation of the workshop! Thank you for that!"
"A really well-performed lecture, highly professional, but with a perfect explanation."
Are you registered for a MIAC Academy already?
Join our team.
Are you interested in joining us and contributing to our team success? We are looking forward to receiving your application and to getting to know you soon. Please send your full application including your CV, Motivation Letter and References to our HR department.
Working at MIAC
Working at MIAC
Currently, there are no open positions.
Latest news and achievements.
Also follow us on LinkedIn for our latest news and achievements.
New leadership announcement
New leadership announcement
MIAC is excited to announce the appointment of Marika Grunze, MBA, and Prof. Dr. Marco Düring as co-CEOs, effective February 01st, 2023. Marika and Marco will continue to build a stronger business and to strengthen MIAC’s next phase of growth as innovative and trusted imaging CRO and research partner in neuroscience. Read more ...